RB1 and osteosarcoma: In terms of response to chemotherapeutic treatment, Iida et al. [41] showed that the SaOS-2 osteosarcoma cell line, lacking active Rb, was less sensitive to the growth-suppressing effect of methotrexate compared to cell lines with wild-type Rb gene.